Global Generative AI in Life Sciences Market 2025-2029

Description

List of Tables

The generative AI in life sciences market is forecasted to grow by USD 1,055.8 mn during 2024-2029, accelerating at a CAGR of 20.3% during the forecast period. The report on the generative AI in life sciences market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by imperative to enhance research and development efficiency, proliferation of high volume, multimodal biological data, and advancements in foundational AI and computing infrastructure.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	18.1%
CAGR	20.3%
Incremental Value	$1,055.8 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's generative AI in life sciences market is segmented as below:

By Application

Drug discovery
Personalized medicine
Clinical trials

By Technology

Novel molecule generation
Protein sequence design
Synthetic gene design

By Deployment

Cloud-based
On-premises
Hybrid

By Geographical Landscape

North America
Europe
APAC
Middle East and Africa
South America

This study identifies the emergence of integrated, closed-loop discovery platforms as one of the prime reasons driving the generative AI in life sciences market growth during the next few years. Also, development of large foundational models for biology and expansion beyond discovery into clinical and regulatory applications will lead to sizable demand in the market.

The report on the generative AI in life sciences market covers the following areas:

Generative AI In Life Sciences Market sizing
Generative AI In Life Sciences Market forecast
Generative AI In Life Sciences Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading generative AI in life sciences market vendors that include AiCure, Atomwise Inc., BenevolentAI, Boehringer Ingelheim International GmbH, Clarivate PLC, Evogene Ltd., Fujitsu Ltd., Google LLC, Insilico Medicine, International Business Machines Corp., Microsoft Corp., NVIDIA Corp., Owkin Inc., PathAI Inc., Recursion Pharmaceuticals Inc., Sanofi SA, Schrodinger Inc., SOPHiA GENETICS, and Tencent Holdings Ltd.. Also, the generative AI in life sciences market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR80727

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by Deployment
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
5.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

6 Market Segmentation by Application

6.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
6.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
6.3 Drug discovery - Market size and forecast 2024-2029
- Chart on Drug discovery - Market size and forecast 2024-2029 ($ million)
- Data Table on Drug discovery - Market size and forecast 2024-2029 ($ million)
- Chart on Drug discovery - Year-over-year growth 2024-2029 (%)
- Data Table on Drug discovery - Year-over-year growth 2024-2029 (%)
6.4 Personalized medicine - Market size and forecast 2024-2029
- Chart on Personalized medicine - Market size and forecast 2024-2029 ($ million)
- Data Table on Personalized medicine - Market size and forecast 2024-2029 ($ million)
- Chart on Personalized medicine - Year-over-year growth 2024-2029 (%)
- Data Table on Personalized medicine - Year-over-year growth 2024-2029 (%)
6.5 Clinical trials - Market size and forecast 2024-2029
- Chart on Clinical trials - Market size and forecast 2024-2029 ($ million)
- Data Table on Clinical trials - Market size and forecast 2024-2029 ($ million)
- Chart on Clinical trials - Year-over-year growth 2024-2029 (%)
- Data Table on Clinical trials - Year-over-year growth 2024-2029 (%)
6.6 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Technology

7.1 Market segments
- Chart on Technology - Market share 2024-2029 (%)
- Data Table on Technology - Market share 2024-2029 (%)
7.2 Comparison by Technology
- Chart on Comparison by Technology
- Data Table on Comparison by Technology
7.3 Novel molecule generation - Market size and forecast 2024-2029
- Chart on Novel molecule generation - Market size and forecast 2024-2029 ($ million)
- Data Table on Novel molecule generation - Market size and forecast 2024-2029 ($ million)
- Chart on Novel molecule generation - Year-over-year growth 2024-2029 (%)
- Data Table on Novel molecule generation - Year-over-year growth 2024-2029 (%)
7.4 Protein sequence design - Market size and forecast 2024-2029
- Chart on Protein sequence design - Market size and forecast 2024-2029 ($ million)
- Data Table on Protein sequence design - Market size and forecast 2024-2029 ($ million)
- Chart on Protein sequence design - Year-over-year growth 2024-2029 (%)
- Data Table on Protein sequence design - Year-over-year growth 2024-2029 (%)
7.5 Synthetic gene design - Market size and forecast 2024-2029
- Chart on Synthetic gene design - Market size and forecast 2024-2029 ($ million)
- Data Table on Synthetic gene design - Market size and forecast 2024-2029 ($ million)
- Chart on Synthetic gene design - Year-over-year growth 2024-2029 (%)
- Data Table on Synthetic gene design - Year-over-year growth 2024-2029 (%)
7.6 Market opportunity by Technology
- Market opportunity by Technology ($ million)
- Data Table on Market opportunity by Technology ($ million)

8 Market Segmentation by Deployment

8.1 Market segments
- Chart on Deployment - Market share 2024-2029 (%)
- Data Table on Deployment - Market share 2024-2029 (%)
8.2 Comparison by Deployment
- Chart on Comparison by Deployment
- Data Table on Comparison by Deployment
8.3 Cloud-based - Market size and forecast 2024-2029
- Chart on Cloud-based - Market size and forecast 2024-2029 ($ million)
- Data Table on Cloud-based - Market size and forecast 2024-2029 ($ million)
- Chart on Cloud-based - Year-over-year growth 2024-2029 (%)
- Data Table on Cloud-based - Year-over-year growth 2024-2029 (%)
8.4 On-premises - Market size and forecast 2024-2029
- Chart on On-premises - Market size and forecast 2024-2029 ($ million)
- Data Table on On-premises - Market size and forecast 2024-2029 ($ million)
- Chart on On-premises - Year-over-year growth 2024-2029 (%)
- Data Table on On-premises - Year-over-year growth 2024-2029 (%)
8.5 Hybrid - Market size and forecast 2024-2029
- Chart on Hybrid - Market size and forecast 2024-2029 ($ million)
- Data Table on Hybrid - Market size and forecast 2024-2029 ($ million)
- Chart on Hybrid - Year-over-year growth 2024-2029 (%)
- Data Table on Hybrid - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by Deployment
- Market opportunity by Deployment ($ million)
- Data Table on Market opportunity by Deployment ($ million)

9 Customer Landscape

9.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Geographic Landscape

10.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
10.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
10.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
10.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
10.5 APAC - Market size and forecast 2024-2029
- Chart on APAC - Market size and forecast 2024-2029 ($ million)
- Data Table on APAC - Market size and forecast 2024-2029 ($ million)
- Chart on APAC - Year-over-year growth 2024-2029 (%)
- Data Table on APAC - Year-over-year growth 2024-2029 (%)
10.6 Middle East and Africa - Market size and forecast 2024-2029
- Chart on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
- Data Table on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
- Chart on Middle East and Africa - Year-over-year growth 2024-2029 (%)
- Data Table on Middle East and Africa - Year-over-year growth 2024-2029 (%)
10.7 South America - Market size and forecast 2024-2029
- Chart on South America - Market size and forecast 2024-2029 ($ million)
- Data Table on South America - Market size and forecast 2024-2029 ($ million)
- Chart on South America - Year-over-year growth 2024-2029 (%)
- Data Table on South America - Year-over-year growth 2024-2029 (%)
10.8 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
10.9 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
10.10 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
10.11 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
10.12 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
10.13 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
10.14 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
10.15 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
10.16 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
10.17 The Netherlands - Market size and forecast 2024-2029
- Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
- Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
- Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
- Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
10.18 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

11 Drivers, Challenges, and Opportunity/Restraints

11.1 Market drivers
11.2 Market challenges
11.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
11.4 Market opportunities/restraints

12 Competitive Landscape

12.1 Overview
12.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
12.3 Landscape disruption
- Overview on factors of disruption
12.4 Industry risks
- Impact of key risks on business

13 Competitive Analysis

13.1 Companies profiled
- Companies covered
13.2 Company ranking index
- Company ranking index
13.3 Market positioning of companies
- Matrix on companies position and classification
13.4 AiCure
- AiCure - Overview
- AiCure - Product / Service
- AiCure - Key offerings
- SWOT
13.5 Atomwise Inc.
- Atomwise Inc. - Overview
- Atomwise Inc. - Product / Service
- Atomwise Inc. - Key offerings
- SWOT
13.6 BenevolentAI
- BenevolentAI - Overview
- BenevolentAI - Product / Service
- BenevolentAI - Key offerings
- SWOT
13.7 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
- SWOT
13.8 Google LLC
- Google LLC - Overview
- Google LLC - Product / Service
- Google LLC - Key offerings
- SWOT
13.9 Insilico Medicine
- Insilico Medicine - Overview
- Insilico Medicine - Product / Service
- Insilico Medicine - Key offerings
- SWOT
13.10 International Business Machines Corp.
- International Business Machines Corp. - Overview
- International Business Machines Corp. - Business segments
- International Business Machines Corp. - Key news
- International Business Machines Corp. - Key offerings
- International Business Machines Corp. - Segment focus
- SWOT
13.11 Microsoft Corp.
- Microsoft Corp. - Overview
- Microsoft Corp. - Business segments
- Microsoft Corp. - Key news
- Microsoft Corp. - Key offerings
- Microsoft Corp. - Segment focus
- SWOT
13.12 NVIDIA Corp.
- NVIDIA Corp. - Overview
- NVIDIA Corp. - Business segments
- NVIDIA Corp. - Key news
- NVIDIA Corp. - Key offerings
- NVIDIA Corp. - Segment focus
- SWOT
13.13 Owkin Inc.
- Owkin Inc. - Overview
- Owkin Inc. - Product / Service
- Owkin Inc. - Key offerings
- SWOT
13.14 PathAI Inc.
- PathAI Inc. - Overview
- PathAI Inc. - Product / Service
- PathAI Inc. - Key offerings
- SWOT
13.15 Recursion Pharmaceuticals Inc.
- Recursion Pharmaceuticals Inc. - Overview
- Recursion Pharmaceuticals Inc. - Product / Service
- Recursion Pharmaceuticals Inc. - Key offerings
- SWOT
13.16 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
13.17 Schrodinger Inc.
- Schrodinger Inc. - Overview
- Schrodinger Inc. - Business segments
- Schrodinger Inc. - Key offerings
- Schrodinger Inc. - Segment focus
- SWOT
13.18 SOPHiA GENETICS
- SOPHiA GENETICS - Overview
- SOPHiA GENETICS - Product / Service
- SOPHiA GENETICS - Key offerings
- SWOT

14 Appendix

14.1 Scope of the report
14.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
14.3 Currency conversion rates for US$
- Currency conversion rates for US$
14.4 Research methodology
- Research methodology
14.5 Data procurement
- Information sources
14.6 Data validation
- Data validation
14.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
14.8 Data synthesis
- Data synthesis
14.9 360 degree market analysis
- 360 degree market analysis
14.10 List of abbreviations
- List of abbreviations